Browse the full directors' dealings record of Medidata Solutions, Inc., a listed equity based in United States. Shares trade on US US, under the authority of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was filed on 12 February 2016 (Retenue fiscale). Among the most active insiders: Hirschfeld Steven Isaac. Every trade is free.
15
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Medidata Solutions, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 15,277 of 25,157 companies
45.1
score / 100
Value
35
Quality
55
FCF yld-4.9%
Earn yld2.5%
EV/EBITDA·
ROE-28%
Gross mgn75%
Net mgn8.2%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Medidata Solutions, Inc. is a company that specializes in cloud-based clinical trial management solutions. It provides services and technologies to help pharmaceutical and biotechnology companies optimize their research and development processes.